Experienced in Propionic Acidemia

Jun S. Ye

168 Changhai Road, 
Shanghai, CN 
Experienced in Propionic Acidemia
168 Changhai Road, 
Shanghai, CN 
OverviewLocationsClinical Research

Overview

Jun Ye practices in Shanghai, China. Ye is rated as an Experienced expert by MediFind in the treatment of Propionic Acidemia. Their top areas of expertise are Malonyl-CoA Decarboxylase Deficiency, Methylmalonic Acidemia, Ornithine Transcarbamylase Deficiency, Pancreaticoduodenectomy, and Gastrostomy.

Their clinical research consists of co-authoring 622 peer reviewed articles and participating in 2 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, they have co-authored 1 article in the study of Propionic Acidemia.

Locations

168 Changhai Road, Shanghai, 200433, China
Other Locations
No. 155, North Nanjing Street, Shenyang, 110001, China
1665 KongJiang Road, Shanghai, 200092, China
No. 366, Taihu Road, Taizhou, China
508 Huancheng West Road, Shaoxing, 312000, China
No. 246, Heping Road, Hefei, 230011, China
88 Jiefang Road, Hangzhou, 310009, China

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

2 Clinical Trials

A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
A Prospective, Randomized, Double-Blind Comparison of LY900014 to Insulin Lispro in Combination With Insulin Glargine or Insulin Degludec in Adults With Type 1 Diabetes
Enrollment Status: Completed
Publish Date: February 08, 2023
Intervention Type: Drug
Study Drugs: LY900014, Insulin Lispro, Insulin Glargine, Insulin Degludec
Study Phase: Phase 3
Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection
Study to Evaluate Pharmacokinetic and Safety of Albuvirtide Between Intravenous Drip and Intravenous Injection
Enrollment Status: Completed
Publish Date: January 09, 2023
Intervention Type: Drug
Study Drug: Albuvirtide
Study Phase: Phase 1
View 1 Less Clinical Trial

622 Total Publications

NIR-light triggered photodynamic therapy combined with hypoxia activated chemotherapy for anti-tumor effects.
NIR-light triggered photodynamic therapy combined with hypoxia activated chemotherapy for anti-tumor effects.
Journal: Nanoscale
Published: December 16, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Ye's expertise for a condition
ConditionClose
    View All 8 Advanced Conditions
    View All 92 Experienced Conditions
    Want to save this expert for later?
    Sign Up
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile